← Evidence map

SynthesisAging2021

Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease.

Hai-Yong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33686024